To evaluate the effect of Saroglitazar Magnesium (2 mg and 4 mg) compared with Placebo on resolution of steatohepatitis on overall histopathological reading and no worsening of liver fibrosis at Week 76/EOT.
University of Colorado Hospital
Amanda Wieland, MD
Protocol Number: 21-3466
More information available at ClinicalTrials.gov: NCT05011305
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers